ロード中...
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use
Topical calcineurin inhibitors (TCI) are a relatively new class of drugs used in dermatology. There are two drug forms available – tacrolimus 0.03% or 0.1% ointment and 1.0% pimecrolimus cream. The drugs act by inhibiting synthesis of proinflammatory cytokines. The only approved indication for using...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3834721/ https://ncbi.nlm.nih.gov/pubmed/24278069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pdia.2013.35619 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|